Methylene blue modulates functional connectivity in the human brain.
Publication/Presentation Date
6-1-2017
Abstract
Methylene blue USP (MB) is a FDA-grandfathered drug used in clinics to treat methemoglobinemia, carbon monoxide poisoning and cyanide poisoning that has been shown to increase fMRI evoked blood oxygenation level dependent (BOLD) response in rodents. Low dose MB also has memory enhancing effect in rodents and humans. However, the neural correlates of the effects of MB in the human brain are unknown. We tested the hypothesis that a single low oral dose of MB modulates the functional connectivity of neural networks in healthy adults. Task-based and task-free fMRI were performed before and one hour after MB or placebo administration utilizing a randomized, double-blinded, placebo-controlled design. MB administration was associated with a reduction in cerebral blood flow in a task-related network during a visuomotor task, and with stronger resting-state functional connectivity in multiple regions linking perception and memory functions. These findings demonstrate for the first time that low-dose MB can modulate task-related and resting-state neural networks in the human brain. These neuroimaging findings support further investigations in healthy and disease populations.
Volume
11
Issue
3
First Page
640
Last Page
648
ISSN
1931-7565
Published In/Presented At
Rodriguez, P., Singh, A. P., Malloy, K. E., Zhou, W., Barrett, D. W., Franklin, C. G., Altmeyer, W. B., Gutierrez, J. E., Li, J., Heyl, B. L., Lancaster, J. L., Gonzalez-Lima, F., & Duong, T. Q. (2017). Methylene blue modulates functional connectivity in the human brain. Brain imaging and behavior, 11(3), 640–648. https://doi.org/10.1007/s11682-016-9541-6
Disciplines
Diagnosis | Medicine and Health Sciences | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Radiology
PubMedID
26961091
Department(s)
Department of Radiology and Diagnostic Medical Imaging
Document Type
Article